Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leuprorelin in Central Precocious Puberty
NCT02427958Phase 4Completed
- Sponsor
- Takeda
- Start
- Aug 2015
- Primary completion
- Nov 2018
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of leuprolide in central precocious puberty (CPP), sponsored by Takeda. Started Aug 2015; status: completed.
02
Drugs
leuprolide
03
Conditions
central precocious puberty (CPP)
Beyond the preview
Go deeper on NCT02427958.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02427958.